TAM
Tocqueville Asset Management Portfolio holdings
AUM
$6.55B
This Quarter Return
+11.72%
1 Year Return
+21.88%
3 Year Return
+89.23%
5 Year Return
+153.22%
10 Year Return
+366.25%
AUM
$6.12B
AUM Growth
+$6.12B
(+11%)
Cap. Flow
+$106M
Cap. Flow
% of AUM
1.74%
Top 10 Holdings %
Top 10 Hldgs %
27.02%
Holding
559
New
43
Increased
166
Reduced
231
Closed
25
Top Buys
| 1 |
Air Products & Chemicals
APD
|
$43.6M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
$14.8M |
| 3 |
ON Semiconductor
ON
|
$14.8M |
| 4 |
Nike
NKE
|
$13.3M |
| 5 |
Pfizer
PFE
|
$12.8M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$27.7M |
| 2 |
Keurig Dr Pepper
KDP
|
$18.9M |
| 3 |
Charles Schwab
SCHW
|
$14.5M |
| 4 |
Abbott
ABT
|
$14.2M |
| 5 |
Lumentum
LITE
|
$14M |
Sector Composition
| 1 | Technology | 20.8% |
| 2 | Consumer Discretionary | 12.25% |
| 3 | Industrials | 11.94% |
| 4 | Healthcare | 10.91% |
| 5 | Financials | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
LyondellBasell Industries
LYB
$17.4B
| $219K | ﹤0.01% |
+2,145
| New | +$219K |
|
502
Live Nation Entertainment
LYV
$37.6B
| $218K | ﹤0.01% |
+2,062
| New | +$218K |
|
503
TJX Companies
TJX
$155B
| $218K | ﹤0.01% |
+2,146
| New | +$218K |
|
504
Eastman Chemical
EMN
$7.76B
| $217K | ﹤0.01% |
+2,170
| New | +$217K |
|
505
GoDaddy
GDDY
$19.9B
| $216K | ﹤0.01% |
+1,818
| New | +$216K |
|
506
Monster Beverage
MNST
$62B
| $214K | ﹤0.01% |
3,606
-600
| -14% | -$35.6K |
|
507
Invesco Semiconductors ETF
PSI
$713M
| $213K | ﹤0.01% |
+3,775
| New | +$213K |
|
508
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8B
| $213K | ﹤0.01% |
1,800
| – | – |
|
509
Cardinal Health
CAH
$36B
| $212K | ﹤0.01% |
1,894
-221
| -10% | -$24.7K |
|
510
Simply Good Foods
SMPL
$2.88B
| $211K | ﹤0.01% |
6,200
| – | – |
|
511
FTI Consulting
FCN
$5.43B
| $210K | ﹤0.01% |
+1,000
| New | +$210K |
|
512
Super Micro Computer
SMCI
$23.8B
| $209K | ﹤0.01% |
+207
| New | +$209K |
|
513
Host Hotels & Resorts
HST
$11.8B
| $208K | ﹤0.01% |
10,045
-10,970
| -52% | -$227K |
|
514
Conagra Brands
CAG
$9.19B
| $207K | ﹤0.01% |
7,000
| – | – |
|
515
Brown & Brown
BRO
$31.4B
| $204K | ﹤0.01% |
+2,327
| New | +$204K |
|
516
Lantern Pharma
LTRN
$46.3M
| $167K | ﹤0.01% |
+19,000
| New | +$167K |
|
517
UNIFI
UFI
$80.2M
| $160K | ﹤0.01% |
26,666
| – | – |
|
518
Cidara Therapeutics
CDTX
$1.61B
| $150K | ﹤0.01% |
163,000
+68,000
| +72% | +$62.6K |
|
519
LXP Industrial Trust
LXP
$2.66B
| $141K | ﹤0.01% |
15,679
| – | – |
|
520
BioXcel Therapeutics
BTAI
$52.7M
| $136K | ﹤0.01% |
48,250
-2,000
| -4% | -$5.64K |
|
521
Zymeworks
ZYME
$1.07B
| $117K | ﹤0.01% |
+11,140
| New | +$117K |
|
522
Immix Biopharma
IMMX
$64M
| $116K | ﹤0.01% |
37,800
+17,800
| +89% | +$54.6K |
|
523
Esperion Therapeutics
ESPR
$490M
| $107K | ﹤0.01% |
+39,750
| New | +$107K |
|
524
OraSure Technologies
OSUR
$230M
| $92.8K | ﹤0.01% |
15,089
+2,512
| +20% | +$15.4K |
|
525
Peloton Interactive
PTON
$3.1B
| $81.7K | ﹤0.01% |
19,070
| – | – |
|